Literature DB >> 9671281

Disruption of the retinal basal lamina during early embryonic development leads to a retraction of vitreal end feet, an increased number of ganglion cells, and aberrant axonal outgrowth.

W Halfter1.   

Abstract

Bacterial collagenase was injected into the vitreous of the eye of chick and quail embryos. Immunocytochemical and ultrastructural studies revealed that the collagenase dissolved the retinal basal lamina of the injected eye. The basal lamina disruption was first detectable 1 hour after enzyme injection and was complete within 3 hours. With further development, the retinal basal lamina was not reestablished; newly developing neuroepithelium in the peripheral retina, however, generated an intact basal lamina. Western blot analysis showed that Clostridial collagenase degraded various collagens but spared noncollagenous proteins. Basal lamina disruption of embryonic day 3 to 6 retinae led to the retraction of the end feet of the neuroepithelial cells, caused an increase in the number of Islet-1+ cells (most likely ganglion cells), an increase in the thickness of the optic fiber layer, and aberrant growth of optic axons on their way toward the optic disc. None of these changes were observed when retinal basal laminae were disrupted at later stages of development. The present data demonstrate that the retinal basal lamina, by anchoring the neuroepithelial cells to the pial surface of the retina, has an important function in the development of the normal cytoarchitecture of this structure. It is proposed that the altered extracellular environment in the vitreal part of the retina, resulting in the retraction of the neuroepithelial end feet, is responsible for the increased number of Islet-1+ cells and the aberrant axonal navigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671281     DOI: 10.1002/(sici)1096-9861(19980720)397:1<89::aid-cne7>3.0.co;2-e

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

1.  Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma.

Authors:  A Radu Aricescu; Iain W McKinnell; Willi Halfter; Andrew W Stoker
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.

Authors:  Ophélie Vacca; Brahim El Mathari; Marie Darche; José-Alain Sahel; Alvaro Rendon; Deniz Dalkara
Journal:  J Vis Exp       Date:  2015-04-19       Impact factor: 1.355

3.  Laminin deficits induce alterations in the development of dopaminergic neurons in the mouse retina.

Authors:  Viktória Dénes; Paul Witkovsky; Manuel Koch; Dale D Hunter; Germán Pinzón-Duarte; William J Brunken
Journal:  Vis Neurosci       Date:  2007-08-22       Impact factor: 3.241

4.  Embryonic retinal cells and support to mature retinal neurons.

Authors:  Jennifer J Stanke; Andy J Fischer
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

5.  Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.

Authors:  Deniz Dalkara; Kathleen D Kolstad; Natalia Caporale; Meike Visel; Ryan R Klimczak; David V Schaffer; John G Flannery
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

6.  Genetic deletion of laminin isoforms β2 and γ3 induces a reduction in Kir4.1 and aquaporin-4 expression and function in the retina.

Authors:  Petra G Hirrlinger; Thomas Pannicke; Ulrike Winkler; Thomas Claudepierre; Shweta Varshney; Christine Schulze; Andreas Reichenbach; William J Brunken; Johannes Hirrlinger
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

7.  The receptor tyrosine phosphatase CRYPalpha promotes intraretinal axon growth.

Authors:  M M Ledig; F Haj; J L Bixby; A W Stoker; B K Mueller
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

8.  Subretinal Glial Membranes in Eyes With Geographic Atrophy.

Authors:  Malia M Edwards; D Scott McLeod; Imran A Bhutto; Rhonda Grebe; Maeve Duffy; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.